Cargando…

Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes

Background. The aims of this study were (1) to examine the renoprotective effects of alogliptin and (2) to establish urinary angiotensinogen (AGT) as a prognostic marker of renoprotective effects of alogliptin in patients with type 2 diabetes (T2D). Methods. In 43 patients with T2D (18 women, 66.1 ±...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizushige, Tomoko, Kobori, Hiroyuki, Nishijima, Yoko, Yano, Yuichiro, Sakata, Koji, Hayakawa, Manabu, Nishiyama, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562181/ https://www.ncbi.nlm.nih.gov/pubmed/26380312 http://dx.doi.org/10.1155/2015/517472

Ejemplares similares

Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients
por: Mizushige, Tomoko, et al.
Publicado: (2016)

Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease
por: Nishijima, Yoko, et al.
Publicado: (2014)

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
por: Yoshimoto, Takuo, et al.
Publicado: (2017)

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy
por: Ogawa, Susumu, et al.
Publicado: (2009)

Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy
por: Kamiyama, Masumi, et al.
Publicado: (2013)

High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5
por: Wang, Juan, et al.
Publicado: (2017)

Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)

Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
por: Cruz‐López, Edwyn O., et al.
Publicado: (2022)

Detailed Localization of Augmented Angiotensinogen mRNA and Protein in Proximal Tubule Segments of Diabetic Kidneys in Rats and Humans
por: Kamiyama, Masumi, et al.
Publicado: (2014)

Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
por: Sun, Wei, et al.
Publicado: (2014)

Intrarenal Oxidative Stress and Augmented Angiotensinogen are Precedent to Renal Injury in Zucker Diabetic Fatty Rats
por: Suzaki, Yuki, et al.
Publicado: (2006)

Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy
por: Takamatsu, Masanori, et al.
Publicado: (2008)

Possible renoprotective mechanisms of SGLT2 inhibitors
por: Nishiyama, Akira, et al.
Publicado: (2023)

Urinary Angiotensinogen as a Biomarker of Nephropathy in Childhood
por: Urushihara, Maki, et al.
Publicado: (2011)

The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules
por: Ohashi, Naro, et al.
Publicado: (2019)

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
por: Shima, Hisato, et al.
Publicado: (2019)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Urinary excretion of renin and angiotensinogen in hypertensive children and adolescents
por: Zając, Magdalena, et al.
Publicado: (2019)

Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
por: Valias, Gabriela Ribeiro, et al.
Publicado: (2022)

Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes
por: Terami, Takahiro, et al.
Publicado: (2013)

Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes
por: Soltysiak, Jolanta, et al.
Publicado: (2014)

Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension
por: Kuroczycka-Saniutycz, Elżbieta, et al.
Publicado: (2013)

Urinary angiotensinogen as a marker of elevated blood pressure in patients with chronic kidney disease
por: Jung, Chan-Young, et al.
Publicado: (2021)

The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2018)

Effect of Vitamin D on Urinary Angiotensinogen Level in Early Diabetic Nephropathy
por: Mahapatra, Himansu Sekhar, et al.
Publicado: (2021)

Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations
por: Kosaki, Keisei, et al.
Publicado: (2023)

Structure and functions of angiotensinogen
por: Lu, Hong, et al.
Publicado: (2016)

Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion
por: Mansuri, Asifhusen, et al.
Publicado: (2015)

Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2019)

Alogliptin benzoate for management of type 2 diabetes
por: Saisho, Yoshifumi
Publicado: (2015)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus
por: Takeda, Hiroshi, et al.
Publicado: (2019)

Urinary Angiotensinogen and Progression of Chronic Kidney Disease: Results from KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022)

Relationship Between Urinary Angiotensinogen and Mortality in Patients with Heart Failure with Reduced Ejection Fraction
por: Örsçelik, Özcan, et al.
Publicado: (2023)

Angiotensinogen and the Modulation of Blood Pressure
por: Shu, Zimei, et al.
Publicado: (2021)

Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial
por: Irie, Yoko, et al.
Publicado: (2018)

Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1
por: Zhang, Lihong, et al.
Publicado: (2017)

Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus
por: Lee, Min Jin, et al.
Publicado: (2017)

Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitus
por: Ba Aqeel, Sheeba, et al.
Publicado: (2019)

Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease
por: Ishigaki, Sayaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vcojsngec4e1no722875diefti